Outcomes , such as range of motion , recurrence , and clinical success , were frequently defined , however many different definitions were used .
This systematic review summarizes the outcome reporting st and ards in Dupuytren ’s disease treatment research .
A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren's disease: a 6-week follow-up study.
PURPOSE The dem and for percutaneous needle fasciotomy ( PNF ) as treatment for Dupuytren 's disease is increasing because of its limited invasiveness , good outcome , limited number of complications , quick recovery , and overall patient satisfaction . This r and omized controlled trial was design ed to test whether these short-term expectations are sound by comparing this treatment with limited fasciectomy ( LF ) with regard to these aspects . METHODS We treated 166 rays : 88 by PNF and 78 by LF .  Total passive extension deficit ( TPED ) improvement at 1 week and at 6 weeks were the primary outcome parameters ; patient satisfaction , h and -function recovery , and complication rate were secondary outcome parameters . We used the Disabilities of the Arm , Shoulder , and H and question naire to measure disabilities of the upper extremity before and after treatment and all adverse effects and complications were recorded . RESULTS Overall TPED improvement was best at 6 weeks . In the PNF group TPED improved by 63 % versus 79 % in the LF group ; this difference was statistically significant . Results at the proximal interphalangeal joint were worse than those at the metacarpophalangeal and distal interphalangeal joints for both the PNF and LF groups . The rays classified before surgery as Tubiana stages I and II showed no difference between these treatments , but for rays higher than stage II LF clearly was superior to PNF as a treatment modality . The rate of major complications in the LF group was 5 % versus 0 % in the PNF group . Patient satisfaction was almost equal but direct h and function after treatment was considered better in the PNF group , as was the degree of discomfort that patients experienced . This was underscored by the Disabilities of the Arm , Shoulder , and H and scores in the PNF group , which were significantly lower than those in the LF group at all time points measured . CONCLUSIONS In the short term and in cases with a TPED of 90 degrees or less PNF is a good treatment alternative to LF for treatment of Dupuytren 's disease . TYPE OF STUDY /LEVEL OF EVIDENCE Therapeutic , Level
Outcomes , such as range of motion , recurrence , and clinical success , were frequently defined , however many different definitions were used .
This systematic review summarizes the outcome reporting st and ards in Dupuytren ’s disease treatment research .